LEXICON PHARMACEUTICALS INC LXRX 5.25 12.01.21
NOTE 5.250%12/0 · US DOMESTIC · CUSIP 528872AB0
12
institutional holders
$88.1mprincipal reported held*
$66.1mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($526.0k this quarter). Holder counts are more reliable.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| CITADEL ADVISORS LLC 0.03% of their portfolio | 31.8m $23.9m | — |
| Tetragon Partners GP Ltd 1.67% of their portfolio | 14.5m $11.2m | — |
| LAZARD ASSET MANAGEMENT LLC 0.01% of their portfolio | 12.5m $9.3m | — |
| WOLVERINE ASSET MANAGEMENT LLC 0.17% of their portfolio | 12.2m $9.1m | — |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.01% of their portfolio | 10.5m $8.5m | — |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 4.5m $3.1m | — |
| DeepCurrents Investment Group LLC 0.03% of their portfolio | 1.0m $760.0k | — |
| Verition Fund Management LLC 0.02% of their portfolio | 709.0k $526.0k | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 320.0k $214.0k | — |
| MacKay Shields LLC 0.00% of their portfolio | 30.0k $22.0k | — |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 30.0k $20.7k | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |